【标题】中国专家成功探索“组合拳”新疗法，HER2阳性乳腺癌脑转移治疗有新突破
【正文】中新网上海1月12日电（记者 陈静）乳腺癌是全球女性第一高发肿瘤。在中国，HER2阳性患者占总患者数为20%—30%，其中约50%的患者极易发生脑转移。近日，中国专家成功探索出一种“组合拳”新疗法，为HER2阳性乳腺癌脑转移治疗带来了新的突破。
据悉，这种新疗法采用了多种手段联合治疗，包括手术、放疗、化疗和靶向治疗等。通过这种“组合拳”的方式，不仅能够提高治疗效果，还能降低患者的复发率和死亡率。
目前，这种新疗法已经在部分医院进行了临床试验，并取得了良好的效果。试验结果显示，采用这种新疗法的患者在治疗后的生存期明显延长，且复发率和死亡率均有所下降。
英语如下：
====
“News Headline: Chinese Experts Successfully ====
“News Headline: Chinese Experts Successfully Develop New Treatment Method, Achieve Breakthrough in the Treatment of HER2-Positive Breast Cancer with Brain Metastasis
Keywords: Breast Cancer, HER2-Positive, Brain Metastasis Treatment
News Content: [Title] Chinese Experts Successfully Explore a “Combination Boxing” New Treatment Method, Achieve New Breakthroughs in the Treatment of HER2-Positive Breast Cancer with Brain Metastasis
[Body] Shanghai, January 12 (Reporter Chen Jing) Breast cancer is the most common tumor among women worldwide. In China, patients with HER2-positive account for 20% -30% of the total number of patients, of which about 50% are prone to brain metastasis. Recently, Chinese experts successfully explored a new “combination boxing” treatment method, bringing new breakthroughs to the treatment of HER2-positive breast cancer with brain metastasis.
It is reported that this new treatment method uses a combination of multiple treatments, including surgery, radiotherapy, chemotherapy and targeted therapy. Through this “combination boxing” approach, it not only improves treatment effectiveness, but also reduces patient recurrence rates and mortality.
At present, this new treatment method has been tested in some hospitals and has achieved good results. The test results show that patients treated with this new treatment method have significantly prolonged survival after treatment, and both recurrence rates and mortality rates have decreased.”
【来源】http://www.chinanews.com/life/2024/01-12/10145211.shtml
Views: 1